Physician profile
James Storey
NPI 1083665442
$9,811.07
in general payments reported to CMS, 2019-2025
29 companies · $667 in 2025
The $667 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,161 · 2020: $837 · 2021: $2,222 · 2022: $2,444 · 2023: $1,206 · 2024: $1,274 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,962 · Travel and Lodging: $1,185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,961.64 |
| Travel and Lodging | $1,185.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,638.83 | 2019-2025 | Ensite Precision, Ensite, Jot Dx |
| Medtronic, INC. | $1,780.41 | 2022-2025 | Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $1,518.27 | 2019-2025 | Watchman Flx, Acuity Steerable, Ingevity+ |
| Atricure, INC. | $538.86 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $276.77 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $273.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $230.97 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $161.25 | 2023 | Optimizer |
| Pfizer INC. | $160.70 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $142.85 | 2019-2021 | |
| Amgen INC. | $133.90 | 2020-2021 | |
| Heartflow, INC. | $100.25 | 2022 | |
| Altathera Pharmaceuticals LLC | $97.97 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $90.84 | 2020-2022 | |
| Biosense Webster, INC. | $78.23 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baylis Medical Company INC | $65.60 | 2021 | |
| Philips North America LLC | $65.00 | 2023 | |
| Amarin Pharma, INC. | $61.78 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $59.86 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.98 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.04 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $38.84 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $37.18 | 2022 | |
| Irhythm Technologies, INC. | $33.94 | 2022 | |
| Sanofi-Aventis U.S. LLC | $31.01 | 2020-2022 | |
| Novo Nordisk INC | $29.65 | 2021-2023 | Ozempic |
| Regeneron Healthcare Solutions, INC. | $25.77 | 2021 | |
| Esperion Therapeutics, INC. | $18.97 | 2021 | |
| Vifor Pharma, INC. | $13.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Storey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.